Cre-mediated recombination in pituitary somatotropes

Genesis

Volumn 47, Issue 1, 2009, Pages 55-60

  Nasonkin, Igor O ^a   Potok, Mary Anne ^a   Camper, Sally A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Anterior pituitary gland; Cell specific expression; Growth hormone; Prolactin; Transgene

Indexed keywords

BETA ACTIN; BETA GALACTOSIDASE; CRE RECOMBINASE; GROWTH HORMONE; INTEGRASE;

ADENOHYPOPHYSIS; ADULTHOOD; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; DEVELOPMENT; ENZYME ACTIVITY; GENE CLUSTER; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENETIC RECOMBINATION; GENETIC TRANSCRIPTION; GROWTH HORMONE SECRETING CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENE; ANIMAL; ANIMAL EMBRYO; CELL LINE; CYTOLOGY; GENETIC ENGINEERING; GENETICS; HUMAN; METABOLISM; METHODOLOGY; PRENATAL DEVELOPMENT; RAT;

RATTUS;

ANIMALS; CELL LINE; EMBRYO, MAMMALIAN; GENETIC ENGINEERING; GROWTH HORMONE; HUMANS; INTEGRASES; MICE; RATS; RECOMBINATION, GENETIC; SOMATOTROPHS; TRANSGENES;

EID: 67449087329     PISSN: 1526954X     EISSN: 1526968X     Source Type: Journal    
DOI: 10.1002/dvg.20462     Document Type: Article

References (33)

1. Akita S, Readhead C, Stefaneanu L, Fine J, Tampanaru-Sarmesiu A, Kovacs K, Melmed S. 1997. Pituitary-directed leukemia inhibitory factor transgene forms Rathke's cleft cysts and impairs adult pituitary function. A model for human pituitary Rathke's cysts. J Clin Invest 99:2462-2469.
2. Behringer RR, Mathews LS, Palmiter RD, Brinster RL. 1988. Dwarf mice produced by genetic ablation of growth hormone-expressing cells. Genes Dev 2:453-461.
3. Bennani-Baiti IM, Asa SL, Song D, Iratni R, Liebhaber SA, Cooke NE. 1998. DNase I-hypersensitive sites I and II of the human growth hormone locus control region are a major developmental activator of somatotrope gene expression. Proc Natl Acad Sci USA 95:10655-10660.
4. Beyea JA, Sawicki G, Olson DM, List E, Kopchick JJ, Harvey S. 2006. Growth hormone (GH) receptor knockout mice reveal actions of GH in lung development. Proteomics 6:341-348.
5. Bingham NC, Verma-Kurvari S, Parada LF, Parker KL. 2006. Development of a steroidogenic factor 1/Cre transgenic mouse line. Genesis 44:419-424.
6. Bonnefont X, Lacampagne A, Sanchez-Hormigo A, Fino E, Creff A, Mathieu MN, Smallwood S, Carmignac D, Fontanaud P, Travo P, Alonso G, Courtois-Coutry N, Pincus SM, Robinson IC, Mollard P. 2005. Revealing the large-scale network organization of growth hormone-secreting cells. Proc Natl Acad Sci USA 102:16880-16885.
7. Brinkmeier ML, Gordon DF, Dowding JM, Saunders TL, Kendall SK, Sarapura VD, Wood WM, Ridgway EC, Camper SA. 1998. Cell-specific expression of the mouse glycoprotein hormone alpha-subunit gene requires multiple interacting DNA elements in transgenic mice and cultured cells. Mol Endocrinol 12:622-633.
8. Burton FH, Hasel KW, Bloom FE, Sutcliffe JG. 1991. Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene. Nature 350:74-77.
9. Chandrashekar V, Dawson CR, Martin ER, Rocha JS, Bartke A, Kopchick JJ. 2007. Age-related alterations in pituitary and testicular functions in long-lived growth hormone receptor gene-disrupted mice. Endocrinology 148:6019-6025.
10. Charles MA, Mortensen AH, Potok MA, Camper SA. 2008. Pitx2 deletion in pituitary gonadotropes is compatible with gonadal development, puberty and fertility. Genesis 46:507-514.
11. Charles MA, Saunders TL, Wood WM, Owens K, Parlow AF, Camper SA, Ridgway EC, Gordon DF. 2006. Pituitary-specific Gata2 knockout: Effects on gonadotrope and thyrotrope function. Mol Endocrinol 20:1366-1377.
12. Clark RP, Schuenke M, Keeton SM, Staron RS, Kopchick JJ. 2006. Effects of growth hormone and insulin-like growth factor I on muscle in mouse models of human growth disorders. Horm Res 66 (Suppl 1):26-34.
13. Cushman LJ, Burrows HL, Seasholtz AF, Lewandoski M, Muzyczka N, Camper SA. 2000. Cre-mediated recombination in the pituitary gland. Genesis 28:167-174.
14. Cushman LJ, Camper SA. 2001. Molecular basis of pituitary dysfunction in mouse and human. Mamm Genome 12:485-494.
15. Egecioglu E, Andersson IJ, Bollano E, Palsdottir V, Gabrielsson BG, Kopchick JJ, Skott O, Bie P, Isgaard J, Bohlooly YM, Bergstrom G, Wickman A. 2007. Growth hormone receptor deficiency in mice results in reduced systolic blood pressure and plasma renin, increased aortic eNOS expression, and altered cardiovascular structure and function. Am J Physiol Endocrinol Metab 292:E1418-E1425.
16. Frawley LS, Boockfor FR. 1991. Mammosomatotropes: Presence and functions in normal and neoplastic pituitary tissue. Endocr Rev 12:337-355.
17. Japon MA, Rubinstein M, Low MJ. 1994. In situ hybridization analysis of anterior pituitary hormone gene expression during fetal mouse development. J Histochem Cytochem 42:1117-1125.
18. Jin Y, Surabhi RM, Fresnoza A, Lytras A, Cattini PA. 1999. A role for A/ T-rich sequences and Pit-1/GHF-1 in a distal enhancer located in the human growth hormone locus control region with preferential pituitary activity in culture and transgenic mice. Mol Endocrinol 13:1249-1266.
19. Jones BK, Monks BR, Liebhaber SA, Cooke NE. 1995. The human growth hormone gene is regulated by a multicomponent locus control region. Mol Cell Biol 15:7010-7021.
20. Jorgez CJ, De Mayo FJ, Matzuk MM. 2006. Inhibin alpha-iCre mice: Cre deleter lines for the gonads, pituitary, and adrenal. Genesis 44: 183-188.
21. Kendall SK, Saunders TL, Jin L, Lloyd RV, Glode LM, Nett TM, Keri RA, Nilson JH, Camper SA. 1991. Targeted ablation of pituitary gonadotropes in transgenic mice. Mol Endocrinol 5:2025-2036.
22. Lira SA, Crenshaw EB III, Glass CK, Swanson LW, Rosenfeld MG. 1988. Identification of rat growth hormone genomic sequences targeting pituitary expression in transgenic mice. Proc Natl Acad Sci USA 85:4755-4759.
23. Lira SA, Kalla KA, Glass CK, Drolet DW, Rosenfeld MG. 1993. Synergistic interactions between Pit-1 and other elements are required for effective somatotroph rat growth hormone gene expression in transgenic mice. Mol Endocrinol 7:694-701.
24. Luque RM, Amargo G, Ishii S, Lobe C, Franks R, Kiyokawa H, Kineman RD. 2007. Reporter expression, induced by a growth hormone promoter-driven Cre recombinase (rGHp-Cre) transgene, questions the developmental relationship between somatotropes and lactotropes in the adult mouse pituitary gland. Endocrinology 148:1946-1953.
25. Meyers EN, Lewandoski M, Martin GR. 1998. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat Genet 18:136-141.
26. Muzumdar MD, Tasic B, Miyamichi K, Li L, Luo L. 2007. A global double-fluorescent Cre reporter mouse. Genesis 45:593-605.
27. Naik K, Pittman It, Wolfe A, Miller RS, Radovick S, Wondisford FE. 2006. A novel technique for temporally regulated cell type-specific Cre expression and recombination in the pituitary gonadotroph. J Mol Endocrinol 37:63-69.
28. Nasonkin IO. 2002. Targeting Prophet of Pit1 gene and designing mouse lines for cre-mediated gene targeting in somatotrophs. In: Human Genetics Ph.D. Thesis. Ann Arbor: University of Michigan. p 145.
29. Schneider HJ, Pagotto U, Stalla GK. 2003. Central effects of the somatotropic system. Eur J Endocrinol 149:377-392.
30. Slominski A, Malarkey WB, Wortsman J, Asa SL, Carlson A. 2000. Human skin expresses growth hormone but not the prolactin gene. J Lab Clin Med 136:476-481.
31. Soriano P. 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21:70-71.
32. Walenkamp MJ, Wit JM. 2007. Genetic disorders in the GH IGF-I axis in mouse and man. Eur J Endocrinol 157 (Suppl 1):S15-S26.
33. Yin Z, Williams-Simons L, Parlow AF, Asa S, Kirschner LS. 2008. Pituitary-specific knockout of the Carney complex gene Prkar1a leads to pituitary tumorigenesis. Mol Endocrinol 22:380-387.